Coronavirus R&D Gateway

COVID-19 has elevated, but also exposed scientists. Politicians want clarity, but it’s crucial to explain what is known, unknown and unknowable, says Rolf-Dieter Heuer, chair of the EU group of chief scientific advisers

A flurry of cooperation projects has enabled Europe’s main life sciences research data infrastructure ELIXIR, to team up with EMBL’s bioinformatics institute and work together on building an EU health data space

Academics speak out against ‘ridiculous’ studies that are getting submitted to journals and urge ‘self-restraint’ be restored

Research on COVID-19 is increasing exponentially, but how can experts find it quickly? Utrecht researcher Rens van de Schoot looks to AI for the answer

MEP calls for access to research data before EU makes vaccine bets with €2.3B advance purchase fund

Brussels will negotiate advance purchase agreements, giving manufacturers confidence to invest before they know if vaccines work, and ensuring equitable access for EU27 and low- and middle-income countries around the world

In the new work programme, the European Commission drops plan to spend €32.5M extra on Marie Curie fellowships for researchers travelling to work on international coronavirus projects

Joël Mesot, president of ETH Zurich tells Science|Business how the university is slowly getting back to speed, and why Brussels and Bern ‘may understand each other better’ after the pandemic

‘Adolescents feel the need to contribute during this time, but do not always have opportunities to do so’ – Erasmus researcher Eveline Crone

Sesame, the region’s only synchrotron, is well versed in upheaval, but the pandemic promises more pressure on a shoestring budget